Literature DB >> 1581112

Characterization of cells with osteogenic potential from human marrow.

S E Haynesworth1, J Goshima, V M Goldberg, A I Caplan.   

Abstract

Studies using animal tissue suggest that bone marrow contains cells with the potential to differentiate into cartilage and bone. We report the extension of these studies to include human marrow. Bone marrow from male and female donors of various ages was obtained either from the femoral head or as aspirates from the iliac crest, and introduced into culture. Culture-adherent cells were expanded, subcultured, and then tested for bone and cartilage differentiation potential utilizing two different in vivo assays in nude mice. One assay involved subcutaneous implantation of porous calcium phosphate ceramics loaded with cultured, marrow-derived, mesenchymal cells; the other involved peritoneal implantation of diffusion chambers, also inoculated with cultured, marrow-derived, mesenchymal cells. Histological evaluation showed bone formation in ceramics implanted with cultured, marrow-derived, mesenchymal cells originating from both the femoral head and the iliac crest. Immunocytochemical analysis indicates that the bone is derived from the implanted human cells and not from the cells of the rodent host. No cartilage was observed in any of these ceramic grafts. In contrast, aliquots from the same preparations of cultured, marrow-derived, mesenchymal cells failed to form bone or cartilage in diffusion chambers. These data suggest that human marrow contains cells with osteogenic potential, which can be enriched and expanded in culture. Our findings also suggest that subcutaneous implantation of these cells in porous calcium phosphate ceramics may be a more sensitive in vivo assay than diffusion chambers for measuring their osteogenic lineage potential.

Entities:  

Mesh:

Year:  1992        PMID: 1581112     DOI: 10.1016/8756-3282(92)90364-3

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  235 in total

1.  Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy.

Authors:  Z Hou; Q Nguyen; B Frenkel; S K Nilsson; M Milne; A J van Wijnen; J L Stein; P Quesenberry; J B Lian; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 2.  SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury.

Authors:  A D Bradshaw; E H Sage
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

3.  Multipotent Mesenchymal Stromal Cells for Autoimmune Diseases.

Authors:  Alan Tyndall
Journal:  Transfus Med Hemother       Date:  2008-07-17       Impact factor: 3.747

4.  In vivo bone formation by human bone marrow cells: effect of osteogenic culture supplements and cell densities.

Authors:  S C Mendes; I Van Den Brink; J D De Bruijn; C A Van Blitterswijk
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

5.  Mesenchymal stem cells combined with biphasic calcium phosphate ceramics promote bone regeneration.

Authors:  T L Livingston; S Gordon; M Archambault; S Kadiyala; K McIntosh; A Smith; S J Peter
Journal:  J Mater Sci Mater Med       Date:  2003-03       Impact factor: 3.896

6.  A cultured living bone equivalent enhances bone formation when compared to a cell seeding approach.

Authors:  S C Mendes; M Sleijster; A Van Den Muysenberg; J D De Bruijn; C A Van Blitterswijk
Journal:  J Mater Sci Mater Med       Date:  2002-06       Impact factor: 3.896

7.  Interactions of human osteoprogenitors with porous ceramic following diffusion chamber implantation in a xenogeneic host.

Authors:  R Gundle; C J Joyner; J T Triffitt
Journal:  J Mater Sci Mater Med       Date:  1997-08       Impact factor: 3.896

8.  Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in low-density culture.

Authors:  D S Yoon; Y H Kim; H S Jung; S Paik; J W Lee
Journal:  Cell Prolif       Date:  2011-10       Impact factor: 6.831

9.  Development of a per-operative procedure for concentrated bone marrow adjunction in postero-lateral lumbar fusion: radiological, biological and clinical assessment.

Authors:  G A Odri; A Hami; V Pomero; M Seite; D Heymann; A Bertrand-Vasseur; W Skalli; J Delecrin
Journal:  Eur Spine J       Date:  2012-05-26       Impact factor: 3.134

Review 10.  Tissue engineered bone grafts: biological requirements, tissue culture and clinical relevance.

Authors:  Mirjam Fröhlich; Warren L Grayson; Leo Q Wan; Darja Marolt; Matej Drobnic; Gordana Vunjak-Novakovic
Journal:  Curr Stem Cell Res Ther       Date:  2008-12       Impact factor: 3.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.